tiprankstipranks
Jenoptik AG (GB:0ZPV)
LSE:0ZPV
UK Market

Jenoptik (0ZPV) Earnings Dates, Call Summary & Reports

7 Followers

Earnings Data

Report Date
May 13, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0.17
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Apr 01, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call balances clear operational progress and strategic investments (Dresden fab online, Biophotonics and Smart Mobility momentum, improved cash flow and cost measures) against notable near-term challenges (declines in group revenue and semi lithography, lower EBITDA and EPS, Prodomax volatility and Q1 phasing risk). Management provided constructive 2026 guidance (single-digit revenue growth and 19%–21% EBITDA margin) but flagged market and cost uncertainties. Overall, positives around cash generation, margin resilience in key businesses, and capacity investments are offset by significant top-line and profit declines in 2025, leaving a mixed outlook.
Company Guidance
Jenoptik guided 2026 revenue to be up in the single‑digit percentage range versus 2025, with an EBITDA margin target of 19–21% and CapEx expected to be slightly below last year as it trends toward maintenance levels; management assumes a similar FX headwind of ~1 percentage point and cautioned that Q1 2026 revenue will be below Q1 2025. Management also expects to convert more than 80% of the roughly EUR 591 million backlog into 2026 revenue, expects financial results broadly in line with the prior year amid a debenture refinancing, and flagged model assumptions including ~3% German labor cost inflation from April 2026 plus benefits from its cost‑savings program as one‑off restructuring expenses drop. Overall, the company reiterated it aims to return to profitable growth in 2026 while maintaining cash and capex discipline.
Micro-Optics Fab Commissioned (Dresden)
Brought largest single investment — new micro-optics fab in Dresden — online, providing capacity to support future growth in micro-optics for data communication and AI-driven demand.
Biophotonics Strong Growth
Order intake up ~19% year-on-year and revenue increased ~10% driven by defense and life science applications; EBITDA margin improved to >20%, reflecting better utilization and favorable product mix.
Smart Mobility Traction and Margin Expansion
Revenue up almost 9% in 2025 with mid-single-digit order intake growth; margin improved by >200 basis points to 13.6%, aided by U.S. go-to-market expansion and service footprint.
Semiconductor Inspection Momentum and Resilient Margins
Inspection business delivered strong customer activity and revenue growth despite lithography weakness; semi business retained a robust full-year EBITDA margin of ~26% (and ~29% for Q3+Q4), showing resilience.
Improved Cash Generation and Balance Sheet Strength
Operating cash flow (pre-tax) improved considerably and free cash flow rose by nearly EUR 50 million, enabling significant debt and leverage reduction; CapEx normalized and expected slightly below prior year.
Cost Efficiency and Headcount Reduction
Implemented an efficiency/cost reduction program and leaner organization, reducing FTE headcount by almost 5% year-on-year, contributing to margin protection and cash generation.
Positive 2026 Guidance
Management expects 2026 revenue to be up in the single-digit percentage range and an EBITDA margin of 19%–21%, indicating confidence in returning to profitable growth despite market uncertainties.
Incremental Shareholder Return
Proposed dividend increased to EUR 0.40 for fiscal 2025 (vs EUR 0.38 prior year), signaling commitment to returning cash to shareholders.

Jenoptik (GB:0ZPV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GB:0ZPV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q1)
- / -
0.17
Apr 01, 2026
2025 (Q4)
0.25 / 0.50
0.167199.40% (+0.33)
Nov 12, 2025
2025 (Q3)
0.36 / 0.37
0.46-19.57% (-0.09)
Aug 13, 2025
2025 (Q2)
0.29 / 0.26
0.42-38.10% (-0.16)
May 13, 2025
2025 (Q1)
0.22 / 0.17
0.27-38.15% (-0.10)
Mar 25, 2025
2024 (Q4)
0.42 / 0.44
0.3333.33% (+0.11)
Nov 12, 2024
2024 (Q3)
0.42 / 0.46
0.3821.05% (+0.08)
Aug 09, 2024
2024 (Q2)
0.45 / 0.42
0.3520.00% (+0.07)
May 08, 2024
2024 (Q1)
0.24 / 0.27
0.2128.57% (+0.06)
Mar 27, 2024
2023 (Q4)
0.56 / 0.33
0.36-8.33% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GB:0ZPV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 01, 2026
€27.90€29.09+4.27%
Nov 12, 2025
€18.51€20.61+11.34%
Aug 13, 2025
€18.60€18.46-0.74%
May 13, 2025
€19.15€18.18-5.08%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Jenoptik AG (GB:0ZPV) report earnings?
Jenoptik AG (GB:0ZPV) is schdueled to report earning on May 13, 2026, TBA (Confirmed).
    What is Jenoptik AG (GB:0ZPV) earnings time?
    Jenoptik AG (GB:0ZPV) earnings time is at May 13, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Jenoptik AG stock?
          The P/E ratio of Jenoptik is N/A.
            What is GB:0ZPV EPS forecast?
            Currently, no data Available